Literature DB >> 31371408

ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female.

Gaurav K Gupta1, Liqiang Xi1, Svetlana D Pack1, Jennifer B Jones2, Stefania Pittaluga1, Mark Raffeld1, Elaine S Jaffe3.   

Abstract

Entities:  

Year:  2019        PMID: 31371408      PMCID: PMC6821621          DOI: 10.3324/haematol.2019.230094

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.

Authors:  Kenneth Tou En Chang; Amos Zhi En Tay; Chik Hong Kuick; Huiyi Chen; Elizabeth Algar; Nadine Taubenheim; Janine Campbell; Francoise Mechinaud; Martin Campbell; Leanne Super; Chavit Chantranuwat; S T Yuen; John K C Chan; Chung W Chow
Journal:  Mod Pathol       Date:  2018-12-20       Impact factor: 7.842

Review 2.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

3.  A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.

Authors:  Rajyalakshmi Luthra; Keyur P Patel; Mark J Routbort; Russell R Broaddus; Jonathan Yau; Crystal Simien; Wei Chen; David Z Hatfield; L Jeffrey Medeiros; Rajesh R Singh
Journal:  J Mol Diagn       Date:  2016-12-23       Impact factor: 5.568

4.  ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.

Authors:  John K C Chan; Laurence Lamant; Elizabeth Algar; Georges Delsol; William Y W Tsang; King C Lee; Karin Tiedemann; Chung W Chow
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

5.  KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.

Authors:  Kengo Takeuchi; Young Lim Choi; Yuki Togashi; Manabu Soda; Satoko Hatano; Kentaro Inamura; Shuji Takada; Toshihide Ueno; Yoshihiro Yamashita; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Yuichi Ishikawa; Hiroyuki Mano
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

6.  ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

Authors:  Jeffrey S Ross; Siraj M Ali; Omotayo Fasan; Jared Block; Sumanta Pal; Julia A Elvin; Alexa B Schrock; James Suh; Sahar Nozad; Sungeun Kim; Hwa Jeong Lee; Christine E Sheehan; David M Jones; Jo-Anne Vergilio; Shakti Ramkissoon; Eric Severson; Sugganth Daniel; David Fabrizio; Garrett Frampton; Vince A Miller; Philip J Stephens; Laurie M Gay
Journal:  Oncologist       Date:  2017-10-27

7.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Julien Haroche; Zhan Yao; Jing Ma; Sameer A Parikh; Zhaoming Wang; John Choi; Eunhee Kim; Fleur Cohen-Aubart; Stanley Chun-Wei Lee; Yijun Gao; Jean-Baptiste Micol; Patrick Campbell; Michael P Walsh; Brooke Sylvester; Igor Dolgalev; Olga Aminova; Adriana Heguy; Paul Zappile; Joy Nakitandwe; Chezi Ganzel; James D Dalton; David W Ellison; Juvianee Estrada-Veras; Mario Lacouture; William A Gahl; Philip J Stephens; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Samuel R Briggs; Omotayo Fasan; Jared Block; Sebastien Héritier; Jean Donadieu; David B Solit; David M Hyman; José Baselga; Filip Janku; Barry S Taylor; Christopher Y Park; Zahir Amoura; Ahmet Dogan; Jean-Francois Emile; Neal Rosen; Tanja A Gruber; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2015-11-13       Impact factor: 39.397

  7 in total
  7 in total

1.  Histiocytoses converge through common pathways.

Authors:  Elaine S Jaffe; John K C Chan
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

2.  Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by Alectinib.

Authors:  Yanchu Li; Changle Shi; Yu Wu; Mingmin He; Xueming Xia; Jie Liu; Yu Jiang
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 3.  Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.

Authors:  Qiang He; Wenjie Zhang; Qiang Li
Journal:  BMC Pediatr       Date:  2022-05-25       Impact factor: 2.567

4.  ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.

Authors:  Charlotte Syrykh; Loïc Ysebaert; Sarah Péricart; Solène M Evrard; Fabienne Meggetto; Salim Kanoun; Pierre Brousset; Camille Laurent
Journal:  Virchows Arch       Date:  2020-10-03       Impact factor: 4.064

5.  Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.

Authors:  Yanhua Bai; Wei Sun; Dongfeng Niu; Xin Yang; Xinting Diao; Yang Yu; Dongmei Lin
Journal:  Virchows Arch       Date:  2021-04-07       Impact factor: 4.064

6.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

7.  A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report.

Authors:  Arisa Kurita; Masayuki Yoshida; Takeshi Murata; Akihiko Yoshida; Nachiko Uchiyama; Shin Takayama
Journal:  Int J Surg Case Rep       Date:  2022-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.